Profil
Reid P.
Bissonnette currently works at Xenetic Biosciences, Inc., as Head-Translational Research & Development.
Dr. Bissonnette also formerly worked at Ligand Pharmaceuticals, Inc., as Associate Director, Huyabio International LLC, as Vice President-Pharmacology, Targazyme, Inc., as Vice President-Immuno-Oncology, and Arrivent BioPharma, Inc., as Head-Non-Clinical Research.
Dr. Bissonnette received his undergraduate degree and doctorate degree from McGill University.
Aktiva positioner av Reid Bissonnette
| Företag | Position | Start |
|---|---|---|
| XENETIC BIOSCIENCES, INC. | Teknisk/Vetenskaplig/F&U Direktör | - |
Tidigare kända positioner av Reid Bissonnette
| Företag | Position | Slut |
|---|---|---|
| LIGAND PHARMACEUTICALS INCORPORATED | Företagsledare/Principal | - |
Targazyme, Inc.
Targazyme, Inc. BiotechnologyHealth Technology Develops biopharmaceuticals to improve clinical efficacy and safety in stem cell transplantation, immunotherapy for cancer, regenerative medicine and gene therapy | Företagsledare/Principal | - |
Huyabio International LLC
Huyabio International LLC Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Företagsledare/Principal | - |
| ARRIVENT BIOPHARMA, INC. | Företagsledare/Principal | - |
Reid Bissonnettes utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 6 |
|---|---|
Ligand Pharmaceuticals, Inc.
Ligand Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and sells drug development technologies | Health Technology |
Huyabio International LLC
Huyabio International LLC Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Health Technology |
McGill University
McGill University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Targazyme, Inc.
Targazyme, Inc. BiotechnologyHealth Technology Develops biopharmaceuticals to improve clinical efficacy and safety in stem cell transplantation, immunotherapy for cancer, regenerative medicine and gene therapy | Health Technology |
Xenetic Biosciences, Inc.
Xenetic Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops biologic drugs, novel oncology therapeutics, and vaccinations | Health Technology |
Arrivent BioPharma, Inc.
Arrivent BioPharma, Inc. Pharmaceuticals: OtherHealth Technology Engages in development and commercialization of cancer medicines | Health Technology |
















